@article{f727d538d9af44e6b8353a208f04a39c,
title = "Editorial: Cancer plasticity and the microenvironment: Implications for immunity and therapy response",
keywords = "Cancer plasticity, Epithelial-to-mesenchymal transition (EMT), Heterogeneity, Immune checkpoint inhibitors, Immune evasion, Immunotherapy, Therapy resistance, Tumor microenvironment (TME)",
author = "Andreas Behren and Thompson, {Erik W.} and Anderson, {Robin L.} and Ferrao, {Petranel T.}",
note = "Funding Information: PF is supported by the National Health and Medical Research Council (NHMRC) of Australia (1126048). AB is the recipient of a Fellowship from the Victorian Government Department of Health and Human Services acting through the Victorian Cancer Agency. The Translational Research Institute is supported by a grant from the Australian Government. Funding Information: The Olivia Newton-John Cancer Research Institute acknowledges the support of the Operational Infrastructure Program of Victorian Government.",
year = "2019",
doi = "10.3389/fonc.2019.00276",
language = "English",
volume = "9",
journal = "Frontiers in Oncology",
issn = "2234-943X",
publisher = "Frontiers Media SA",
number = "MAY",
}